ResourceDrug discovery > Lead Discovery
Biomarker discovery service
3 Nov 2025Identifying relevant biomarkers from vast proteomic datasets is a major challenge in drug development. Discover how phenotype-driven discovery simplifies complexity to deliver biomarkers precisely aligned with disease context, tissue specificity, and therapeutic goals. This approach enables faster validation and supports both surface and internal targets, accelerating your path to effective, targeted therapies.
Related products
Request Quote for All Products
Custom Optimer™ Affinity Reagent Development Service
Aptamer GroupAptamer Group is a developer of custom Optimer reagents as antibody mimetics for use as tool affinity reagents, in biomarker discovery, as diagnostic reagents and as therapeutic lead candidates.
Links
Tags
BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.